ALK and T-cell non-Hodgkin lymphoma: We therefore used the CD4/NPM–ALK (CD4NA) thymic T cell lymphoma model12 to investigate the potential contribution of recombinase activating gene (Rag)-mediated TCR rearrangement and TCR signalling to the natural progression of NPM–ALK-driven T-cell lymphoma.